Drugmakers Pull Cold Medications for Infants Off Shelves

Drugmakers have pulled a number of cold and cough medications targeted at children under 2 years old off store shelves. The drugs were pulled after the FDA issued a public health warning about nonprescription cough and cold medicine use. The FDA statement included this warning.

Do not use cough and cold products in children under 2 years of age UNLESS given specific directions to do so by a healthcare provider.

An MSNBC article explains the drugs that were pulled off the shelves.

The Consumer Healthcare Products Association announced Thursday that manufacturers were voluntarily ending sales of over-the-counter oral cough and cold products aimed at infants. The list includes infant drops sold under the leading brand names Dimetapp, Pediacare, Robitussin, Triaminic, Little Colds, and versions of Tylenol that contain cough and cold ingredients.

CVS Caremark Corp. added that it would also end sales of CVS-brand equivalents.

"It's important to point out that these medicines are safe and effective when used as directed, and most parents are using them appropriately," said Linda Suydam, president of the industry trade group.

The article says pediatric and public health groups recommend the following actions for dealing with a child with a cold or cough.

Plenty of fluids and rest.

Suction bulbs to gently clear infants' clogged noses. Saline nose drops loosen thick secretions so noses drain more easily.

A cool-mist humidifier in the child's bedroom.

Acetaminophen or ibuprofen, as recommended by your doctor, to alleviate pain or discomfort - but check that they don't contain extra ingredients.

Some chest creams can ease stuffiness with menthol or other fragrances, but check labels for age restrictions.

The latest news is that an FDA Panel has advised against the use of OTC cold medications in kids aged 2 to 5. The FDA Panel also recommends drugs for this age group to be pulled as well.

Permalink | Our News Feeds